71 related articles for article (PubMed ID: 8925519)
1. p53 alterations in progenitor lesions of the bronchus, esophagus, oral cavity, and colon.
Bennett WP
Cancer Detect Prev; 1995; 19(6):503-11. PubMed ID: 8925519
[TBL] [Abstract][Full Text] [Related]
2. p53 protein accumulates frequently in early bronchial neoplasia.
Bennett WP; Colby TV; Travis WD; Borkowski A; Jones RT; Lane DP; Metcalf RA; Samet JM; Takeshima Y; Gu JR
Cancer Res; 1993 Oct; 53(20):4817-22. PubMed ID: 8402667
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
4. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas.
Shahnavaz SA; Regezi JA; Bradley G; Dubé ID; Jordan RC
J Pathol; 2000 Mar; 190(4):417-22. PubMed ID: 10699989
[TBL] [Abstract][Full Text] [Related]
6. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
7. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
8. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
Kohno H; Hiroshima K; Toyozaki T; Fujisawa T; Ohwada H
Cancer; 1999 Jan; 85(2):341-7. PubMed ID: 10023701
[TBL] [Abstract][Full Text] [Related]
9. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
10. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
12. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
13. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
Brambilla E; Gazzeri S; Lantuejoul S; Coll JL; Moro D; Negoescu A; Brambilla C
Clin Cancer Res; 1998 Jul; 4(7):1609-18. PubMed ID: 9676834
[TBL] [Abstract][Full Text] [Related]
14. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
17. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
20. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.
Chung SM; Kao J; Hyjek E; Chen YT
Int J Oncol; 2007 Dec; 31(6):1351-5. PubMed ID: 17982662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
